Ngenic AB (publ)

As of December 31, 2024, Ngenic AB (publ) has 59.13M shares outstanding.

These figures are as of December 31, 2024. The price-to-sales ratio is 6.78, and the price-to-book ratio stands at 107.62.

These figures are as of December 31, 2024. The EV/Sales ratio of 6.76 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Ngenic AB (publ) trades at an EV/FCF ratio of 441.52, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of December 31, 2024, Ngenic AB (publ) maintains a current ratio of 0.23, meaning it holds 0.2x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended December 31, 2024, Ngenic AB (publ) posted a negative return on equity (ROE) of -2,179.68, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -45.14, reflecting losses generated across the asset base. Inventory turnover of -0.03 indicates how many times Ngenic AB (publ) sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended December 31, 2024, Ngenic AB (publ) posted a gross margin of 101.01, reflecting its pricing power and cost economics. The operating margin of -147.73 and net profit margin of -137.23 provide insight into operational efficiency.

These figures cover the twelve months ended December 31, 2024. Free cash flow yield is negative at -1.31: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -8.73, meaning Ngenic AB (publ) raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Ngenic AB (publ)'s most recent stock split took place on June 3, 2022 with a 250:261 split ratio.

As of December 31, 2024, Ngenic AB (publ) has an Altman Z-Score of -7.59, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.